FDA-wide inventory of property should be finished by end of April, Friedman tells hearing.
This article was originally published in The Tan Sheet
FDA AGENCY-WIDE INVENTORY OF ACCOUNTABLE PROPERTY is expected to be complete by the end of April, agency Lead Deputy Commissioner Michael Friedman, MD, testified at an April 1 House Commerce/Oversight & Investigations Subcommittee hearing on FDA financial management issues. FDA is "nearing the end of the laborious process of reconciling the data gathered from each center with agency records," Friedman said. "The end result, which should be completed by the end of this month, will be a wall-to-wall inventory of all agency accountable property."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC